SPEXIB 150 (Ceritinib)


Active Ingredient



Non-small cell lung cancer


Novartis India Ltd


10 capsules in 1 strip



Delivery Time

6 To 15 days

  • 20% Off Coupan Code GD20
  • Data Privacy and Security
  • Free Shipping on Orders Over $199
Variation Price Quantity Add To Cart
10 Capsule/s $130.00
Add to cart
20 Capsule/s $230.00
Add to cart
30 Capsule/s $320.00
Add to cart

SPEXIB 150 (Ceritinib) 150 mg is a life-saving drug for cancer patients. It is a type of chemotherapy drug that targets specific proteins on the surface of cancer cells, thus blocking their growth and spread. SPEXIB 150 mg is approved to treat certain types of non-small cell lung cancer (NSCLC).
This drug has been used to treat advanced-stage NSCLC that cannot be treated with other medicines or has progressed after treatment. SPEXIB 150 (Ceritinib) 150 mg is also prescribed to treat patients who have tested positive for a specific mutation in the ALK gene. This gene produces an abnormal protein that can cause tumor growth in some types of cancer.


There are no reviews yet.

Be the first to review “SPEXIB 150 (Ceritinib)”

Your email address will not be published. Required fields are marked *